Huadong Medicine Co., Ltd (SHE: 000963)
China
· Delayed Price · Currency is CNY 28.61
-0.11 (-0.38%)
Sep 9, 2024, 1:42 PM CST
Huadong Medicine Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 6, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 49,702 | 72,565 | 82,087 | 70,342 | 46,475 | 42,660 | Upgrade
|
| Market Cap Growth | -35.87% | -11.60% | 16.70% | 51.36% | 8.94% | 10.57% | Upgrade
|
| Enterprise Value | 46,910 | 70,923 | 81,583 | 69,341 | 46,024 | 43,222 | Upgrade
|
| Last Close Price | 28.40 | 40.71 | 45.62 | 38.91 | 25.58 | 23.20 | Upgrade
|
| PE Ratio | 16.05 | 25.12 | 31.94 | 29.58 | 15.87 | 14.43 | Upgrade
|
| PS Ratio | 1.21 | 1.79 | 2.18 | 2.04 | 1.38 | 1.20 | Upgrade
|
| PB Ratio | 2.29 | 3.36 | 4.28 | 4.15 | 3.06 | 3.32 | Upgrade
|
| P/FCF Ratio | 19.76 | 31.24 | 69.06 | 29.92 | 23.98 | 65.81 | Upgrade
|
| P/OCF Ratio | 11.64 | 18.47 | 34.46 | 22.19 | 13.62 | 21.31 | Upgrade
|
| EV/Sales Ratio | 1.14 | 1.75 | 2.16 | 2.01 | 1.37 | 1.22 | Upgrade
|
| EV/EBITDA Ratio | 10.40 | 16.48 | 21.60 | 20.91 | 13.32 | 12.03 | Upgrade
|
| EV/EBIT Ratio | 12.79 | 19.76 | 25.86 | 24.71 | 15.22 | 13.56 | Upgrade
|
| EV/FCF Ratio | 18.65 | 30.54 | 68.64 | 29.50 | 23.74 | 66.67 | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.09 | 0.13 | 0.12 | 0.13 | 0.16 | Upgrade
|
| Debt / EBITDA Ratio | 0.52 | 0.44 | 0.67 | 0.61 | 0.58 | 0.58 | Upgrade
|
| Debt / FCF Ratio | 0.93 | 0.83 | 2.18 | 0.89 | 1.03 | 3.20 | Upgrade
|
| Asset Turnover | 1.19 | 1.26 | 1.30 | 1.35 | 1.48 | 1.74 | Upgrade
|
| Inventory Turnover | 6.16 | 6.25 | 6.07 | 5.96 | 5.56 | 6.09 | Upgrade
|
| Quick Ratio | 1.18 | 1.28 | 1.23 | 1.21 | 1.19 | 1.10 | Upgrade
|
| Current Ratio | 1.54 | 1.71 | 1.73 | 1.67 | 1.70 | 1.64 | Upgrade
|
| Return on Equity (ROE) | 14.58% | 13.97% | 14.02% | 14.56% | 20.75% | 25.12% | Upgrade
|
| Return on Assets (ROA) | 6.63% | 6.94% | 6.78% | 6.85% | 8.28% | 9.80% | Upgrade
|
| Return on Capital (ROIC) | 9.72% | 9.91% | 9.67% | 9.69% | 11.77% | 14.55% | Upgrade
|
| Earnings Yield | 6.23% | 3.91% | 3.04% | 3.27% | 6.07% | 6.59% | Upgrade
|
| FCF Yield | 5.06% | 3.20% | 1.45% | 3.34% | 4.17% | 1.52% | Upgrade
|
| Dividend Yield | 2.44% | 1.42% | 0.64% | 0.75% | 0.90% | 1.21% | Upgrade
|
| Payout Ratio | 34.46% | 20.93% | 23.07% | 19.99% | 20.06% | 20.28% | Upgrade
|
| Buyback Yield / Dilution | -0.15% | -0.11% | -0.00% | 0.00% | -0.00% | 0.44% | Upgrade
|
| Total Shareholder Return | 2.29% | 1.32% | 0.63% | 0.75% | 0.90% | 1.65% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.